packageExagamglogeneAutotemcel

exagamglogene autotemcel

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Exagamglogene autotemcel is a gene therapy used for sickle-cell disease and transfusion-dependent beta thalassemia. It is authorised in the European Union and is a recently approved, still partly investigational therapy.

Summary written by glm-5.3-flash from Wikidata Q107400400 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:exagamglogene autotemcel
ATC codes:B06AX05
DrugBank:DB15572
Wikidata:Q107400400

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown